Restricts abortion access model confidence 90%
Nullifies FDA approval of mifepristone and bars future approvals of abortion drugs by prohibiting pregnancy from being treated as an illness, so less medication abortion access.
Any prohibited approval of an abortion drug is hereby nullified.
✓ Quote verified word for word in the bill text
Restricts abortion access model confidence 80%
Prohibits HHS/FDA from treating pregnancy as an illness when approving abortion drugs or maintaining REMS, so tighter regulation of medication abortion providers.
The Department of Health and Human Services, including the Food and Drug Administration, shall not treat pregnancy as an illness for purposes of-- (1) approving any abortion drug under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355); or (2) imposing or maintaining any risk evaluation and mitigation strategy for an abortion drug under section 505-1 of such Act (21 U.S.C. 355-1).
✓ Quote verified word for word in the bill text
Stage: Committee · step 2 of 6
Why the model tagged it this way: The bill substantively addresses abortion by nullifying the existing FDA approval of mifepristone (the primary medication abortion drug) and prohibiting future approvals or REMS on the basis that pregnancy cannot be treated as an illness; this restricts medication abortion access and imposes stricter regulatory barriers on abortion drugs/providers. No other listed topics are substantively addressed.
| Date | Chamber | Action |
|---|---|---|
| 2025-01-28 | Libra | Introduced in House |
| 2025-01-28 | Libra | Introduced in House |
| 2025-01-28 | House | Referred to the House Committee on Energy and Commerce. |